Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Chinese Patent Office
Johnson and Johnson
Daiichi Sankyo

Generated: February 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 205171

« Back to Dashboard

NDA 205171 describes ALMOTRIPTAN MALATE, which is a drug marketed by Ajanta Pharma Ltd, Mylan Pharms Inc, and Teva Pharms Usa, and is included in three NDAs. It is available from three suppliers. Additional details are available on the ALMOTRIPTAN MALATE profile page.

The generic ingredient in ALMOTRIPTAN MALATE is almotriptan malate. There are six drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the almotriptan malate profile page.
Summary for 205171
Applicant:Mylan Pharms Inc
Ingredient:almotriptan malate
Therapeutic Class:Antimigraine Agents
Pharmacology for NDA: 205171
Suppliers and Packaging for NDA: 205171
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ALMOTRIPTAN MALATE almotriptan malate TABLET;ORAL 205171 ANDA Mylan Pharmaceuticals Inc. 0378-5245 N 0378-5245-85
ALMOTRIPTAN MALATE almotriptan malate TABLET;ORAL 205171 ANDA Mylan Pharmaceuticals Inc. 0378-5246 N 0378-5246-85

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 6.25MG BASE
Approval Date:Nov 9, 2015TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 12.5MG BASE
Approval Date:Nov 9, 2015TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Chinese Patent Office
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.